XSPA - XpresSpa: $100 Million War Chest To Rollout Airport COVID-19 Testing
- Uniquely positioned for airport COVID-19 testing and riding the wave of increasing regulation for testing before and after travel.
- $100 million war chest to go after this opportunity.
- Air travel increased over the holiday period and 4Q earnings could provide positive catalysts for the stock.
- Upside price target of $2.61 for 74% upside, with downside support from large cash position.
- This is a speculative investment with the risk profile of investing in a venture-stage start-up.
For further details see:
XpresSpa: $100 Million War Chest To Rollout Airport COVID-19 Testing